vs

Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and Cardlytics, Inc. (CDLX). Click either name above to swap in a different company.

Cardlytics, Inc. is the larger business by last-quarter revenue ($50.9M vs $39.9M, roughly 1.3× COLONY BANKCORP INC). Over the past eight quarters, COLONY BANKCORP INC's revenue compounded faster (19.6% CAGR vs -9.6%).

Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

CBAN vs CDLX — Head-to-Head

Bigger by revenue
CDLX
CDLX
1.3× larger
CDLX
$50.9M
$39.9M
CBAN
Faster 2-yr revenue CAGR
CBAN
CBAN
Annualised
CBAN
19.6%
-9.6%
CDLX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBAN
CBAN
CDLX
CDLX
Revenue
$39.9M
$50.9M
Net Profit
$8.2M
Gross Margin
Operating Margin
-12.0%
Net Margin
20.6%
Revenue YoY
-25.5%
Net Profit YoY
24.1%
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAN
CBAN
CDLX
CDLX
Q1 26
$39.9M
Q4 25
$36.9M
$50.9M
Q3 25
$32.8M
$47.0M
Q2 25
$32.5M
$58.0M
Q1 25
$30.0M
$56.4M
Q4 24
$30.8M
$68.3M
Q3 24
$28.6M
$61.1M
Q2 24
$27.9M
$64.0M
Net Profit
CBAN
CBAN
CDLX
CDLX
Q1 26
$8.2M
Q4 25
Q3 25
$5.8M
$-72.7M
Q2 25
$8.0M
$-9.3M
Q1 25
$6.6M
$-13.3M
Q4 24
Q3 24
$5.6M
$-145.2M
Q2 24
$5.5M
$-4.3M
Operating Margin
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
25.9%
-12.0%
Q3 25
22.2%
-146.6%
Q2 25
30.9%
-22.0%
Q1 25
27.6%
-24.9%
Q4 24
28.8%
-12.2%
Q3 24
24.6%
-243.1%
Q2 24
24.8%
-24.7%
Net Margin
CBAN
CBAN
CDLX
CDLX
Q1 26
20.6%
Q4 25
Q3 25
17.7%
-154.7%
Q2 25
24.6%
-16.0%
Q1 25
22.0%
-23.5%
Q4 24
Q3 24
19.7%
-237.6%
Q2 24
19.6%
-6.7%
EPS (diluted)
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
$0.42
$-0.15
Q3 25
$0.33
$-1.36
Q2 25
$0.46
$-0.18
Q1 25
$0.38
$-0.26
Q4 24
$0.43
$-0.36
Q3 24
$0.32
$-2.90
Q2 24
$0.31
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAN
CBAN
CDLX
CDLX
Cash + ST InvestmentsLiquidity on hand
$295.8M
$48.7M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$380.4M
$-6.5M
Total Assets
$3.7B
$285.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAN
CBAN
CDLX
CDLX
Q1 26
$295.8M
Q4 25
$48.7M
Q3 25
$44.0M
Q2 25
$46.7M
Q1 25
$52.0M
Q4 24
$65.6M
Q3 24
$67.0M
Q2 24
$71.2M
Total Debt
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
$258.1M
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$248.0M
$213.6M
Q3 24
$213.2M
Q2 24
$212.9M
Stockholders' Equity
CBAN
CBAN
CDLX
CDLX
Q1 26
$380.4M
Q4 25
$375.9M
$-6.5M
Q3 25
$302.3M
$-4.7M
Q2 25
$293.9M
$58.7M
Q1 25
$286.9M
$64.1M
Q4 24
$278.7M
$70.0M
Q3 24
$276.1M
$69.7M
Q2 24
$264.7M
$210.0M
Total Assets
CBAN
CBAN
CDLX
CDLX
Q1 26
$3.7B
Q4 25
$3.7B
$285.6M
Q3 25
$3.2B
$292.8M
Q2 25
$3.1B
$361.1M
Q1 25
$3.2B
$369.1M
Q4 24
$3.1B
$392.7M
Q3 24
$3.1B
$399.4M
Q2 24
$3.0B
$534.4M
Debt / Equity
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
0.69×
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
0.89×
3.05×
Q3 24
3.06×
Q2 24
1.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAN
CBAN
CDLX
CDLX
Operating Cash FlowLast quarter
$13.0M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
$-5.5M
$13.0M
Q3 25
$14.4M
$1.8M
Q2 25
$15.8M
$1.2M
Q1 25
$17.9M
$-6.7M
Q4 24
$23.4M
$3.0M
Q3 24
$20.5M
$1.4M
Q2 24
$1.1M
$4.4M
Free Cash Flow
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
$-6.9M
$13.0M
Q3 25
$14.1M
$1.7M
Q2 25
$15.8M
$903.0K
Q1 25
$17.6M
$-6.8M
Q4 24
$22.3M
$2.9M
Q3 24
$20.2M
$878.0K
Q2 24
$990.0K
$4.1M
FCF Margin
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
-18.7%
25.5%
Q3 25
42.9%
3.7%
Q2 25
48.5%
1.6%
Q1 25
58.7%
-12.1%
Q4 24
72.5%
4.2%
Q3 24
70.6%
1.4%
Q2 24
3.5%
6.5%
Capex Intensity
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
3.7%
0.0%
Q3 25
1.1%
0.0%
Q2 25
0.3%
0.6%
Q1 25
1.2%
0.2%
Q4 24
3.5%
0.2%
Q3 24
1.0%
0.8%
Q2 24
0.5%
0.4%
Cash Conversion
CBAN
CBAN
CDLX
CDLX
Q1 26
Q4 25
Q3 25
2.48×
Q2 25
1.99×
Q1 25
2.71×
Q4 24
Q3 24
3.64×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAN
CBAN

Net Interest Income$29.2M73%
Noninterest Income$10.7M27%

CDLX
CDLX

Segment breakdown not available.

Related Comparisons